Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

Fig. 1

Cumulative cases and deaths averted (in 1000 s) by 2050 from M72/AS01E and BCG-revaccination scenarios. The top of the bar is the median estimate of the number averted for each scenario compared to the estimated number predicted by 2050 with the Status Quo no-new-vaccine baseline with 95% uncertainty range. The horizontal line is the median value of the Basecase for each vaccine. The cases and deaths averted by each scenario are compared to 72.2 (63.3–79.7) million incident tuberculosis cases and 13.8 (12.9–15.2) million tuberculosis deaths predicted by the Status Quo baseline between 2025 and 2050

Back to article page